Search - tctmd.com

Displaying 441 - 460 of 497

Sort: Relevancy | Date

News Daily News

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

Michael O'Riordan

June 07, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2016

Shelley Wood

May 31, 2016

News Conference News EuroPCR 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

Shelley Wood

May 20, 2016

News Conference News EuroPCR 2016

As Technique Inches Forward, Outcomes Improve for Transcatheter Treatment of Severe Calcific Mitral Disease

Shelley Wood

May 18, 2016

News Daily News

Patients With Low Aortic Valve Gradient May Be Less Likely to Reap TAVR’s Benefits

Todd Neale

May 16, 2016

News Daily News

Anticoagulation May Not Be Necessary When Replacing Aortic Valve With Bioprosthesis, Meta-analysis Suggests

Todd Neale

May 12, 2016

News Daily News

Study Supports Safety of Forgoing ICU Stay After TAVR in Selected Patients

Todd Neale

April 27, 2016

News Daily News

Transcatheter Tricuspid Valve Repair Appears Feasible in First-in-Human Case

April 03, 2015

News Daily News

Clinical Stroke Rate After Open AVR Higher than Expected

Leah Lawrence

May 08, 2014

News Conference News EuroPCR 2012

TAVR Studies Tease Out Influences on Clinical Outcome

Caitlin E. Cox

May 18, 2012

News Conference News EuroPCR 2012

Global Valve-in-Valve Registry: Procedure Technically Challenging, but Highly Feasible

Caitlin E. Cox

May 16, 2012

News Daily News

Local Anesthesia Feasible, Safe in Transfemoral TAVR

May 11, 2012

News Daily News

La Anestesia Local es Viable y Segura en la TAVR Transfemoral

May 11, 2012

News Daily News

CMS Agrees to Cover TAVR for FDA-Approved Use

Caitlin E. Cox

May 07, 2012

News Daily News

French Registry Provides Window into Real-World TAVR Use

Caitlin E. Cox

May 03, 2012

News Daily News

TAVR Suitable Even in Patients with Impaired LVEF

Caitlin E. Cox

April 19, 2012

News Conference News ACC 2012

Study Looks at Long-term Mortality Predictors in TAVR Patients

Jason Kahn

March 27, 2012

Presentation ACC 2012

Late (≥ 2 year) Clinical and Echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-Risk Cohort of The PARTNER Trial

Presenter: Susheel K. Kodali

March 26, 2012

News Conference News ACC 2012

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

March 24, 2012

Advertisement

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

TCTMD’s Top 10 Most Popular Stories for May 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

As Technique Inches Forward, Outcomes Improve for Transcatheter Treatment of Severe Calcific Mitral Disease

Patients With Low Aortic Valve Gradient May Be Less Likely to Reap TAVR’s Benefits

Anticoagulation May Not Be Necessary When Replacing Aortic Valve With Bioprosthesis, Meta-analysis Suggests

Study Supports Safety of Forgoing ICU Stay After TAVR in Selected Patients

Transcatheter Tricuspid Valve Repair Appears Feasible in First-in-Human Case

Clinical Stroke Rate After Open AVR Higher than Expected

TAVR Studies Tease Out Influences on Clinical Outcome

Global Valve-in-Valve Registry: Procedure Technically Challenging, but Highly Feasible

Local Anesthesia Feasible, Safe in Transfemoral TAVR

La Anestesia Local es Viable y Segura en la TAVR Transfemoral

CMS Agrees to Cover TAVR for FDA-Approved Use

French Registry Provides Window into Real-World TAVR Use

TAVR Suitable Even in Patients with Impaired LVEF

Study Looks at Long-term Mortality Predictors in TAVR Patients

Late (≥ 2 year) Clinical and Echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-Risk Cohort of The PARTNER Trial

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content